New Class Of Synthetic Capsules That Mimic Biological Cells Has Wide Array Of Potential Uses

From individual proteins to whole tissues, scientists have been engineering or growing biological mimics for a variety of medical and industrial applications. Bioengineers from the Institute for Medicine and Engineering (IME) at the University of Pennsylvania have designed an artificial capsule that imitates many of the qualities of natural cells. The capsule - dubbed a polymersome - has wide-ranging possibilities, from a new gene-therapy delivery vehicle to an artificial red blood cell. The collaborative study between IME and the University of Minnesota describes the physical properties of the capsules. The team's findings appear in the May 14 issue of Science.

"We've created an entirely new type of synthetic capsule," says co-senior author Daniel Hammer, Ph.D., professor of chemical engineering. "The polymersomes are the same size as natural cells, but their outer membrane is much tougher than the phospholipid membrane of biological cells. And, they have the capacity to be undetectable by the human immune system so could be used to deliver all kinds of therapies to specific targets."

The capsules were produced using block copolymer chemistry. A carbon-based polymer and an organic solvent are dried on a wire. Then water is added to the system and the wire is zapped with electricity. Over time, as the polymer film lifts off the wire's surface, capsules automatically form.

"Using this method we've been able to make capsules the size of natural cells from synthetic polymers, which has never been done before," notes Dennis Discher, Ph.D., co-senior author and assistant professor of mechanical, chemical, and bioengineering. The largest artificial cell made prior to these are a micron in diameter, whereas the polymersomes range from 10 to 35 microns. Most human cells are 10 microns.

Polymersomes are also biocompatible. A chemical tag made from polyethylene oxide is used to make lipid capsules and other biological delivery vehicles invisibl

Contact: Karen Young Kreeger
University of Pennsylvania School of Medicine

Page: 1 2 3

Related biology news :

1. New Class Of Molecular Cues Guides Nervous System Wiring
2. University Of Kentucky Professor Teaches First Reproductive Laboratory Science Class In The United States
3. New Class Of Protease Inhibitors May Be Effective In Treating One Of Latin Americas Most Devastating Diseases
4. Severity Of Classic Heat Stroke Recognized
5. Rapid Progress Reported On New Class Of Anti-Cancer Drugs
6. Bacterial Protein Structure Hints At Mechanism Of A Class Of Premature Aging Diseases
7. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
8. Synthetic antifreeze could prevent ice growth
9. Synthetic clay could assist radioactive waste cleanup
10. Synthetic Lock Binds Some Molecules, Excludes Others
11. A Synthetic Peptide Destroys Brain Plaque Implicated in Alzheimers Disease

Post Your Comments:

(Date:7/18/2020)... ... July 16, 2020 , ... A ... of the Invictus Medical Neoasis™ active noise control device to attenuate typical noises ... the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and other ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com , ... biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European Hematology ... Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase 1 ...
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled ... accelerated Point of Care Testing solutions (POCT). Check local listings for more info. , ... medical offices and are shipped to labs throughout the country. Results are then available ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... Texas (PRWEB) , ... July 29, 2020 , ... ... solutions today announced the launch of its new tagline, “BUILDING FOR LIFE.” The ... biopharmaceutical industry and around the globe, requiring fast track capacity to provide patients ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... of the top radiation centers in 16 countries, has reached its 20th anniversary ... is now in routine use at top universities including University of Pennsylvania, University ...
(Date:7/18/2020)... Ohio (PRWEB) , ... July 16, 2020 , ... ... data solutions to aid in the early detection and prevention of high-burden diseases, ... to enable US-based hospitals and healthcare organizations to utilize existing data in order ...
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
Breaking Biology Technology:
Cached News: